INREBIC
Impact Biomedicines, Inc.
Mark For: INREBIC® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86690908 |
| Registration Number | 4931750 |
| Mark Literal Elements | INREBIC |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2016-04-05 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Camille M. Miller |
| Attorney Docket Number | 373290/CELG- |
| Law Office Assigned | M30 |
| Employee Name | MARSH, BRANDON NELSON |
Timeline
| 2015-07-13 | Application Filed |
| 2016-01-19 | Published |
| 2016-01-19 | Published for Opposition |
| 2016-04-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-04-05 | Status: Live/Registered |
| 2016-04-05 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2016-04-05 | Trademark Registered |
| 2019-05-17 | Transaction Date |
| 2021-04-05 | Maintenance Early File Date |
| 2022-04-05 | Maintenance On Time Date |
| 2022-10-05 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  IMPACT BIOMEDICINES, INC. |
| Address | 86 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2015-07-13 |
 TEAS RF New Application | MULTI | 2015-07-13 |
| XSearch Search Summary | XML | 2015-09-21 |
| Offc Action Outgoing | XML | 2015-09-29 |
| Response to Office Action | MULTI | 2015-10-27 |
| Amendment and Mail Process Complete | MULTI | 2015-12-01 |
| Notation to File | XML | 2015-12-05 |
| Examiners Amendment | XML | 2015-12-10 |
| Amendment and Mail Process Complete | MULTI | 2015-12-11 |
| Amendment to Delete or Correct Basis | MULTI | 2015-12-11 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2015-12-11 |
| Publication & Issue Review Complete | MULTI | 2015-12-18 |
| Notice of Publication | XML | 2015-12-30 |
| Notification Of Notice of Publication | XML | 2015-12-30 |
| OG Publication Confirmation | XML | 2016-01-19 |
| Registration Certificate | TIFF | 2016-04-05 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 6543-0632 [8 Pages] | 2018-11-29 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-02-06 | |
| REGISTERED-PRINCIPAL REGISTER | 2016-04-05 | |
| PUBLISHED FOR OPPOSITION | 2016-01-19 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-01-19 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-12-30 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-12-17 | 69712 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2015-12-10 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2015-12-10 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2015-12-10 | 92454 |
| EXAMINER'S AMENDMENT ENTERED | 2015-12-10 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-12-10 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-11-28 | 69712 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-11-28 | 69712 |
| ASSIGNED TO LIE | 2015-11-16 | 69712 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-10-27 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-09-29 | 6325 |
| NON-FINAL ACTION WRITTEN | 2015-09-29 | 92454 |
| NON-FINAL ACTION E-MAILED | 2015-09-29 | 6325 |
| ASSIGNED TO EXAMINER | 2015-09-18 | 92454 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-07-16 | |
| NEW APPLICATION ENTERED IN TRAM | 2015-07-16 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 INREBIC 88207119 not registered Live/Pending |
Celgene Corporation 2018-11-27 |
 INREBIC 86690908 4931750 Live/Registered |
IMPACT BIOMEDICINES, INC. 2015-07-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 